Lincomycin and clindamycin (7 chloro-7 deoxylincomycin) are being used with increasing frequency to treat severe nonenterococcal streptococcal infections. The in vitro susceptibility to lincomycin and clindamycin of groups A, B, and D and nongroupable streptococci has been studied previously (4, (6) (7) (8) 12) ; however, there is little data regarding the susceptibility of other streptococci to these antibiotics. This study was undertaken to determine the susceptibility of the less common serogroups of streptococci to lincomycin and clindamycin and to examine in more detail the susceptibility patterns of the more frequently occurring groups of streptococci.
MATERIALS AND METHODS
Streptococci isolated from clinical specimens submitted to the Diagnostic Bacteriology Laboratory of the Massachusetts General Hospital were studied. In addition, reference strains of some of the less common serogroups obtained from the Center for Disease Control, Atlanta, Ga., and recent isolates from routine throat and stool specimens collected from natives of Ontong Java, British Solomon Islands Protectorate were also tested. The latter were 'included because they were recovered from an isolated atoll population who had never been exposed to lincomycin or clindamycin.
Strains were classified according to serological group by the Lancefield method using extracts obtained by the methods of Rantz and Randall (10) 2 to 10 times less than that of lincomycin. The relative lincomycin and clindamycin susceptibility of strains from the serotypes studied are shown in Fig. 1-3 . Streptococci from groups A, B, and G and Streptococcus bovis were the most susceptible to lincomycin, whereas those from groups A, B, G, F, and L and S. bovis were exquisitely susceptible to clindamycin. Of the streptococci studied, the vast majority from all serotypes were inhibited by concentrations of <0 grouped strains. The MIC of lincomycin and clindamycin for these more resistant strains ranged from 3.1 to 100 ug/ml.
In general, the in vitro susceptibility to lincomycin and clindamycin of strains of streptococci isolated from natives of the Solomon Islands paralleled closely the susceptibility pattern of the respective species of streptococci isolated at the Massachusetts General Hospital (Fig. 1-3 ).
DISCUSSION
Streptococci belonging to serogroup A (4, 6-8), B (7), and nongroupable strains (4, (6) (7) (8) have been previously shown to be susceptible in vitro to lincomycin and clindamycin. This study confirms these results. In addition, the low MIC of lincomycin and clindamycin for streptococci in serogroups C, F, G, H, L, and M indicates that streptococci in these groups are also highly susceptible to both antibiotics. With the major exception of the group D streptococci ANTIMICROB. AGENTS CHEMOTHER. the range of MIC values for lincomycin and clindamycin against organisms in a given serogroup was narrow. Occasionally, however, strains of streptococci from groups F, H, M. 0, P, and Q and nongroupable isolates were significantly more resistant than other serologically similar strains.
Previous studies have suggested that the group D streptococci are resistant to clindamycin and lincomycin (4, (6) (7) (8) 12) . With the exception of Toala et al. (12) , whose studies were limited to enterococci, none of the previous investigators have speciated the group D streptococci. This is important because the group D streptococci consist of so-called enterococci (especiallv S. durans, S. faecalis, and S. faecium) as well as nonenterococcal strains, the most important of which are S. bovis (9) . When the group D streptococci are carefully speciated, it is clear that not all group D streptococci are resistant to clindamycin and lincomycin. Virtually all strains of S. faecalis and S. faecium, which are enterococci, proved resistant to clinically achievable levels of lincomycin and clindamycin as has been shown in previous studies. However, the four "American" strains of S. durans (which are also enterococci), as well as the strains of S. bovis, were quite susceptible to both antibiotics. Three of the four American strains of S. durans were reference strains which had been maintained in the laboratory for an extended period and thus possibly altered. Nevertheless, the divergent susceptibility patterns of the American S. durans and S. bovis strains as contrasted with S. faecalis and S. faecium may have important clinical implications and re-emphasizes the importance of careful speciation of the group D streptococci. Interestingly, the S. durans strains isolated in the Solomon Islands demonstrated a susceptibility pattern similar to the "American" strains of S. faecium. This is not surprising since these organisms are closely related and are, in fact, distinguished only by their ability to ferment certain sugars, the most important of which are mannitol and arabinose. The Solomon Islands strains of S. durans failed to ferment mannitol, but were variable in their ability to ferment arabinose. Moreover, all produced acid from sucrose. a characteristic in common with S. faecium. Thus, it is quite possible that these strains are more closely related to S. faecium (or are biochemical variants of S. faecium) than the "American" strains of S. durans (all of which failed to ferment mannitol, arabinose, and sucrose). With the above noted exception, there was no significant difference in susceptibility of the Solomon Islands streptococci, which had not been previously exposed to lincomycin or clindamycin, when compared with similar serogroups isolated in America.
Our studies point out the importance of careful identification and speciation of streptococci when considering the clinical use of lincomycin or clindamycin for streptococcal infections. Previous 
